RSS Updates
Email Updates
Amylin (AMLN) CEO Dan Bradbury earned a base salary of almost $560,000 last year according to the company proxy. He will probably do as well in 2008.
During the last twelve months, shares in the company are off 40%.
Yesterday, Federal regulators said they are working on a stronger label for a widely used diabetes drug marketed by Amylin Pharmaceuticals Inc. and Eli Lilly & Co. as deaths continue to be reported despite earlier government warnings.
The stock is likely to stay down for a long time
Douglas A. McIntyre
Buzz up!
Digg
Fark
Facebook
Tip'd
Tweet This
